search
Back to results

A Multidisciplinary Intervention in Total Knee Arthroplasty (MultiKnee)

Primary Purpose

Osteoarthritis; Primary, Degenerative Joint Disease of Knee

Status
Recruiting
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
Osteoarthritis education, exercise and CBT
Total Knee Arthroplasty
Sponsored by
Lovisenberg Diakonale Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Osteoarthritis; Primary focused on measuring Total knee arthroplasty, Physiotherapy, Cognitive behavioral therapy, e-therapy

Eligibility Criteria

18 Years - 79 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Scheduled for TKA for OA at Lovisenberg, Oslo; Martina Hansen, Bærum, or Coastal Hospital Hagevik, Bergen
  2. Age 18 - 79 years
  3. ASA grade 1-3
  4. KL grade 3 or 4
  5. BMI<40
  6. Able to read and write in Norwegian

Exclusion Criteria:

  • Diagnosis of dementia or sero-positive rheumatic disease
  • Previously undergone uni or patellofemoral prosthesis in the index knee
  • Large axis deviation or instability requiring use of hinged implants
  • Scheduled for unicompartmental arthroplasty or revision surgery

Sites / Locations

  • Haukeland University Hospital - Kysthospitalet HagevikRecruiting
  • Lovisenberg Diaconal HospitalRecruiting
  • Martina Hansens HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Active Comparator

Arm Label

Non-surgical group

Combined group

Surgery only (standard care)

Arm Description

Osteoarthritis education, exercise and eCBT

Total knee arthroplasty + osteoarthritis education, exercise and eCBT

Total knee arthroplasty + standard physiotherapy

Outcomes

Primary Outcome Measures

Change in the knee injury and osteoarthritis score (KOOS) pain subscale
KOOS is a knee-specific, patient administered questionnaire developed to evaluate short- and long-term symptoms and functioning in subjects with knee injury and osteoarthritis. KOOS is validated for use in total knee arthroplasty and has been shown to be a valid, reliable and responsive measure. KOOS is a patient-administered questionnaire. The KOOS is a knee joint specific questionnaire with 42 items designed to assess patients' opinions about their difficulties with activity due to problems with their knees during the past week. The pain subscale of the KOOS consists of 9 items that assess frequency of pain and pain severity in different situations. Each of the 42 items carries equal weighting (0-4), with higher scores indicating better functioning. The pain subscale score will be transformed to a 0-100 scale, with 0 representing extreme knee problems and 100 representing no problems.

Secondary Outcome Measures

Knee injury and osteoarthritis score (KOOS) subscores: Other symptoms, activities of daily living (ADL), function in sport and recreation, and knee-related quality of life (QOL)
KOOS is a knee-specific questionnaire developed to evaluate short- and long-term symptoms and functioning in subjects with knee injury and osteoarthritis. The KOOS is a knee joint specific questionnaire with 42 items designed to assess patients' opinions about their difficulties with activity due to problems with their knees during the past week. KOOS has 5 subscales: pain, other symptoms, activities of daily living (ADL), function in sport and recreation, and knee-related QOL. The KOOS has been validated for use in TKA and has been shown to be valid, reliable and responsive. Each of the 42 items carries equal weighting (0-4), with higher scores indicating better functioning. Each of the subscale scores are transformed to a 0-100 scale, with 0 representing extreme knee problems and 100 representing no problems. KOOS is a patient-administered questionnaire.
The 30 second sit to stand test
The 30-second sit to stand test will be used to assess functional lower extremity strength. This test is performed using a chair of standard height without arms. The participant is encouraged to complete as many full stands as possible within 30 seconds.
Brief Pain inventory
The Brief Pain Inventory (BPI) will be used to measure pain (56). The BPI is a brief patient-completed questionnaire that consists of four items that measure pain intensity (on an 11-point numeric rating scale from 0-10), seven questions on pain interference with functioning, a body map to localize the pain and one item on pain relief.
EuroQol-5D-5L
The widely used EuroQol-5 (EQ-5D-5L) will be used to measure health-related quality of life. The EQ5D-5L consists of two parts: A descriptive system (Mobility, self-care, usual activities, pain/discomfort and anxiety/depression) and the EQ-VAS that record patients self-rated health on a visual analog scale that range from 0 - 100, higher levels indicate better self-rated health. The descriptive system can be converted to a single summary index number where lower levels indicate poorer health-related quality of life.
The Forgotten Joint Score
The Forgotten Joint Score will be used to assess how natural the prosthesis feels after total knee arthroplasty. The scoring system consists of 12 items that assess patients agreement with 12 statements, that range from 1 (never) to 5 (mostly). The raw score is transformed to a 0-100 score and then reversed to obtain the final score. A higher score indicate better outcome.
Pain Catastrophizing Scale
The Pain Catastrophizing scale (PCS) will be used to measure catastrophic thinking related to pain. The scale consist of 13 items that range from 0 -4. The PCS assesses three dimensions of catastrophizing (i.e., rumination (range 0-16), magnification (range: 0-12, helplessness (range 0 -24). Higher scores indicate higher levels of catastrophic thinking related to pain. A total score can be computed by summing responses to all 13 items. PCS total scores range from 0-52. Higher scores indicate higher levels of catastrophic thinking related to pain.
Patient-acceptable symptom state, perceived treatment failure.
Patient-acceptable symptom state will be measured by a single item question. The patient state wether they consider their knee function satisfactory or not (Yes/No). Perceived treatment failure will be measured by a single item question. The patient state whether their situation is so dissatisfying that they consider the treatment as a failure (Yes/No).
Global perceived effect
The patient rate their level of knee problems compared to their condition before they started their treatment, by choosing on of seven statements that describe the level of improvement/worsening. The statements range from "better - an important improvement" - to "worse, an important worsening".
Adverse events/serious adverse events
All events reported by participant, physiotherapist or documented in the patient's hospital record. During surgery: Number of patients with fractures (Tibia, patella, femur), nerve or vascular injury, rupture of patella tendon, other. Postoperatively: Number of patients with deep infection, any secondary surgery (e.g., skin necrosis or scar tissue adherences, DAIR, MUA, secondary insertion of patella component, partial/total revision surgery), supracondylar femur fracture, patella fracture, permanent n. peroneus paresis, aseptic loosening, polyethylene defect (tibia or patella), instability requiring intervention, thrombophlebitis demanding anticoagulant treatment, pulmonary embolism, myocardial infarction, cerebral insult, other events. Patient-reported myocardial infarction, cerebral insult, pulmonary embolism or DVT within 3 months following intervention. All events reported by patients or physiotherapists - open probe questionnairing

Full Information

First Posted
November 12, 2018
Last Updated
January 16, 2023
Sponsor
Lovisenberg Diakonale Hospital
Collaborators
Haukeland University Hospital, Martina Hansen's Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT03771430
Brief Title
A Multidisciplinary Intervention in Total Knee Arthroplasty
Acronym
MultiKnee
Official Title
A Multidisciplinary Intervention in Total Knee Arthroplasty - a Multicenter, Randomized Controlled Trial in OA Patients (The MultiKnee Trial)
Study Type
Interventional

2. Study Status

Record Verification Date
June 2022
Overall Recruitment Status
Recruiting
Study Start Date
August 28, 2019 (Actual)
Primary Completion Date
December 2023 (Anticipated)
Study Completion Date
December 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Lovisenberg Diakonale Hospital
Collaborators
Haukeland University Hospital, Martina Hansen's Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to investigate the effectiveness of cognitive behavioral therapy delivered as an e-therapy program, combined with physical exercise delivered by physiotherapists, for patients on waiting list for total knee arthroplasty. The patients will be randomized to either 1) a non-surgical program consisting of web-based cognitive behavioral therapy combined with physiotherapy, 2) total knee arthroplasty (TKA) surgery followed by web-based cognitive behavioral therapy combined with physiotherapy, or 3) a control group who undergo TKA followed by standard physiotherapy.
Detailed Description
The study is a multidisciplinary trial testing an intervention delivered by physiotherapists. Up to 20% of total knee arthroplasty (TKA) patients continue to experience moderate/severe pain 12 months after TKA. While physical therapy (PT) and cognitive-behavior therapy (CBT) have shown promise for improving outcomes, they have not been evaluated in combination or in patients at risk for chronic pain after TKA. This trial will evaluate PT+CBT combined, either as a substitute for or as a supplement to TKA for patients at risk for chronic pain after TKA. Pilot/Feasibility study: The study will include a feasibility/pilot study with 15 patients to be performed from November 2018. The intervention and study procedures may be modified based on results from the feasibility/pilot study. Full scale Randomized Controlled Trial (RCT): The full-scale RCT will include 282 patients scheduled for TKA. Patients will be randomly assigned to one of three groups: 1) non-surgical intervention (i.e., PT+CBT), 2) a combination of TKA with pre- and postoperative PT+CBT, or 3) A control group receiving TKA and usual care follow-up. Primary outcome: The Pain subscale from the KOOS. The intervention has the potential to improve outcomes for patients who currently obtain little benefit from standard TKA. Cross-sectional observational study: Patients declining to participate in the RCT will be offered the option to participate in a separate cross-sectional study. The inclusion and exclusion criteria will be identical to the RCT. Patients who agree to participate in the cross-sectional study will complete the same baseline questionnaires as in the RCT and are asked about the reasons they did not want to participate in the RCT.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteoarthritis; Primary, Degenerative Joint Disease of Knee
Keywords
Total knee arthroplasty, Physiotherapy, Cognitive behavioral therapy, e-therapy

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
282 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Non-surgical group
Arm Type
Experimental
Arm Description
Osteoarthritis education, exercise and eCBT
Arm Title
Combined group
Arm Type
Experimental
Arm Description
Total knee arthroplasty + osteoarthritis education, exercise and eCBT
Arm Title
Surgery only (standard care)
Arm Type
Active Comparator
Arm Description
Total knee arthroplasty + standard physiotherapy
Intervention Type
Behavioral
Intervention Name(s)
Osteoarthritis education, exercise and CBT
Other Intervention Name(s)
AktivA
Intervention Description
Osteoarthritis Education 60-min session by AktivA trained PT) Signs/symptoms, risk factors, weight control, treatment Importance of physical activity Appropriate activity & training modalities Exercise and CBT Support 60-min sessions/week for 12 weeks (a total of 24 sessions) led by AktivA and CBT trained PT) Warm-up session Strengthening exercises Functional exercises Stretching Monitoring of CBT progress Review of CBT lessons learned Integration of CBT skills Enhance motivation to continue Online CBT (iCBT) (10 modules completed at home) Pain causes & prevention Pain management Health promotion & stress reduction at home & work Adapting for leisure & work Controlling flare-ups Maintaining & improving results
Intervention Type
Procedure
Intervention Name(s)
Total Knee Arthroplasty
Other Intervention Name(s)
knee replacement
Intervention Description
Standard total knee arthroplasty will be performed.
Primary Outcome Measure Information:
Title
Change in the knee injury and osteoarthritis score (KOOS) pain subscale
Description
KOOS is a knee-specific, patient administered questionnaire developed to evaluate short- and long-term symptoms and functioning in subjects with knee injury and osteoarthritis. KOOS is validated for use in total knee arthroplasty and has been shown to be a valid, reliable and responsive measure. KOOS is a patient-administered questionnaire. The KOOS is a knee joint specific questionnaire with 42 items designed to assess patients' opinions about their difficulties with activity due to problems with their knees during the past week. The pain subscale of the KOOS consists of 9 items that assess frequency of pain and pain severity in different situations. Each of the 42 items carries equal weighting (0-4), with higher scores indicating better functioning. The pain subscale score will be transformed to a 0-100 scale, with 0 representing extreme knee problems and 100 representing no problems.
Time Frame
Before randomization, 12 months after treatment start. Also measured at 3, 6, and 24 months after treatment start.12 months after treatment start will be the primary outcome.
Secondary Outcome Measure Information:
Title
Knee injury and osteoarthritis score (KOOS) subscores: Other symptoms, activities of daily living (ADL), function in sport and recreation, and knee-related quality of life (QOL)
Description
KOOS is a knee-specific questionnaire developed to evaluate short- and long-term symptoms and functioning in subjects with knee injury and osteoarthritis. The KOOS is a knee joint specific questionnaire with 42 items designed to assess patients' opinions about their difficulties with activity due to problems with their knees during the past week. KOOS has 5 subscales: pain, other symptoms, activities of daily living (ADL), function in sport and recreation, and knee-related QOL. The KOOS has been validated for use in TKA and has been shown to be valid, reliable and responsive. Each of the 42 items carries equal weighting (0-4), with higher scores indicating better functioning. Each of the subscale scores are transformed to a 0-100 scale, with 0 representing extreme knee problems and 100 representing no problems. KOOS is a patient-administered questionnaire.
Time Frame
Before randomization. 3, 6, 12 and 24 months following treatment start
Title
The 30 second sit to stand test
Description
The 30-second sit to stand test will be used to assess functional lower extremity strength. This test is performed using a chair of standard height without arms. The participant is encouraged to complete as many full stands as possible within 30 seconds.
Time Frame
Before treatment start. 3, 6, 12 and 24 months following treatment start
Title
Brief Pain inventory
Description
The Brief Pain Inventory (BPI) will be used to measure pain (56). The BPI is a brief patient-completed questionnaire that consists of four items that measure pain intensity (on an 11-point numeric rating scale from 0-10), seven questions on pain interference with functioning, a body map to localize the pain and one item on pain relief.
Time Frame
Before randomization. 3, 6, 12 and 24 months following treatment start
Title
EuroQol-5D-5L
Description
The widely used EuroQol-5 (EQ-5D-5L) will be used to measure health-related quality of life. The EQ5D-5L consists of two parts: A descriptive system (Mobility, self-care, usual activities, pain/discomfort and anxiety/depression) and the EQ-VAS that record patients self-rated health on a visual analog scale that range from 0 - 100, higher levels indicate better self-rated health. The descriptive system can be converted to a single summary index number where lower levels indicate poorer health-related quality of life.
Time Frame
Before randomization. 3, 6, 12 and 24 months following treatment start
Title
The Forgotten Joint Score
Description
The Forgotten Joint Score will be used to assess how natural the prosthesis feels after total knee arthroplasty. The scoring system consists of 12 items that assess patients agreement with 12 statements, that range from 1 (never) to 5 (mostly). The raw score is transformed to a 0-100 score and then reversed to obtain the final score. A higher score indicate better outcome.
Time Frame
Before randomization. 3, 6, 12 and 24 months following treatment start
Title
Pain Catastrophizing Scale
Description
The Pain Catastrophizing scale (PCS) will be used to measure catastrophic thinking related to pain. The scale consist of 13 items that range from 0 -4. The PCS assesses three dimensions of catastrophizing (i.e., rumination (range 0-16), magnification (range: 0-12, helplessness (range 0 -24). Higher scores indicate higher levels of catastrophic thinking related to pain. A total score can be computed by summing responses to all 13 items. PCS total scores range from 0-52. Higher scores indicate higher levels of catastrophic thinking related to pain.
Time Frame
Before randomization. 3, 6, 12 and 24 months following treatment start
Title
Patient-acceptable symptom state, perceived treatment failure.
Description
Patient-acceptable symptom state will be measured by a single item question. The patient state wether they consider their knee function satisfactory or not (Yes/No). Perceived treatment failure will be measured by a single item question. The patient state whether their situation is so dissatisfying that they consider the treatment as a failure (Yes/No).
Time Frame
At 3, 6, 12 and 24 months following treatment start.
Title
Global perceived effect
Description
The patient rate their level of knee problems compared to their condition before they started their treatment, by choosing on of seven statements that describe the level of improvement/worsening. The statements range from "better - an important improvement" - to "worse, an important worsening".
Time Frame
At 3, 6, 12 and 24 months following treatment start.
Title
Adverse events/serious adverse events
Description
All events reported by participant, physiotherapist or documented in the patient's hospital record. During surgery: Number of patients with fractures (Tibia, patella, femur), nerve or vascular injury, rupture of patella tendon, other. Postoperatively: Number of patients with deep infection, any secondary surgery (e.g., skin necrosis or scar tissue adherences, DAIR, MUA, secondary insertion of patella component, partial/total revision surgery), supracondylar femur fracture, patella fracture, permanent n. peroneus paresis, aseptic loosening, polyethylene defect (tibia or patella), instability requiring intervention, thrombophlebitis demanding anticoagulant treatment, pulmonary embolism, myocardial infarction, cerebral insult, other events. Patient-reported myocardial infarction, cerebral insult, pulmonary embolism or DVT within 3 months following intervention. All events reported by patients or physiotherapists - open probe questionnairing
Time Frame
From treatment start until 24 months following treatment start.
Other Pre-specified Outcome Measures:
Title
Pittsburgh Sleep Quality Index
Description
The Pittsburgh Sleep Quality index (PSQI) is a widely-used self-report measure of sleep disturbance during the past month. The PSQI consists of 19 items that measures different aspects of sleep. The 19 items produce 7 component scores (i.e., duration of sleep, sleep disturbance, sleep latency, day dysfunction due to sleepiness, sleep efficiency, overall sleep quality, need for sleep medications) each ranging from 0-3 where higher score indicate poorer sleep. All component scores can be summarized to a global score that range from 0 to 21 where higher scores indicate poorer sleep quality. The PSQI has good validity and reliability.
Time Frame
Before randomization. 3, 6, 12 and 24 months following treatment start
Title
The Hospital Anxiety and Depression Scale
Description
The Hospital Anxiety and Depression Scale (HADS) will be used to measure self-reported psychological distress (depression and anxiety). The scale consists of 14 items, 7 on the depression subscale and 7 on the anxiety subscale. The Norwegian version has excellent psychometric properties. Each subscale range from 0-21 where higher scores indicate higher levels of anxiety or depression. A total score (range 0 - 42) can be calculated from summarizing all the 14 items. Higher scores indicate higher levels of anxiety/depression.
Time Frame
Before randomization. 3, 6, 12 and 24 months following treatment start
Title
The Fear-Avoidance Belief Questionnaire
Description
The Fear-Avoidance Belief Questionnaire (FABQ) will be used to measure pain-related fear of movement. The instrument consists of 2 subscales, fear-avoidance beliefs for work, and fear-avoidance beliefs for physical activity (FABQ-PA). Only the FABQ-PA subscale will be used in this study. The FABQ-PA consists of 4 items where patients rate their agreement with 5 statements about pain and physical activity. The FABQ-PA range from 0-24 and higher scores indicate higher levels of pain-related fear of movement.
Time Frame
Before randomization. 3, 6, 12 and 24 months following treatment start
Title
Health Locus of Control Scale
Description
The Health Locus of Control Scale (HLCS) will be used to measure patients' anticipations between own health and disease behavior and consequences of the behavior. The scale consists of 18 statements. Patients rate their agreement on a 6 point likert scale ranging from disagrees completely to agrees completely. Scoring: The scoring system consists of 3 subscales: The Internal Locus of Control, the Powerful Others Health Locus of Control, and the Chance Health Locus of control. The scores are obtained by summing items for each subscale. Higher scores indicate stronger agreement or inclination towards that particular subscale.
Time Frame
Before randomization. 3, 12 and 24 months following treatment start
Title
Self-reported level of physical activity
Description
Self-reported level of physical activity will be measured using two items from the Norwegian Hunt2 survey that assess frequency of light and hard physical activity, and the Stages of Change for physical activity. The Stages of Change for physical activity assess patients' readiness for physical activity. Patients rate their agreement with five different statements about physical activity.
Time Frame
Before randomization. 3, 6, 12 and 24 months following treatment start
Title
The ActiGraph Professional single-axis accelerometer
Description
The ActiGraph Professional single-axis accelerometer, a body worn sensor system to measure physical activity, will be used to measure time in sedentary and active positions, duration of activity and number of steps during walking
Time Frame
Before treatment start. 6, 12 and 24 months following treatment start
Title
The 40 meters walk test
Description
The 40 meter walk test: The patient is instructed to walk 40 meter under timing.
Time Frame
Before treatment start. 3, 6, 12 and 24 months following treatment start
Title
Stair Climb Test
Description
The Stair Climb Test will be used to measure ascending and descending stair activity, and lower body strength and balance, measured as a participants' time in seconds to ascend and descend a flight of stairs.
Time Frame
Before treatment start. 3, 6, 12 and 24 months following treatment start
Title
Registry-based data on use of health care resources
Description
Use of health care resources will be measured using registry data from the KUHR-system (i.e., control and payment of reimbursements to health service providers), the Norwegian Patient Registry (NPR) FD Trygd social security database, the Norwegian Prescription Database and the Norwegian Arthroplasty registry. All information will be anonymized and linked to each patient using a code number before analysis.
Time Frame
From before randomization until 3, 6, 12 and 24 months after treatment start.
Title
Radiographs: weightbearing AP, lateral view, Rosenberg view and long leg weightbearing AP view (HKA)
Description
X-rays including weightbearing AP, lateral view, Rosenberg view and long leg weightbearing AP view (HKA) weightbearing AP view (HKA). OA severity grading will be performed according to the Kellgren-Lawrence grading system and cartilage thickness.
Time Frame
Before treatment start, 12 months following treatment start.
Title
Screening and recruitment of patients (pilot study with 15 patients).
Description
Number of patients undergoing screening, considered for inclusion, eligible for inclusion, consenting to participate and undergoing randomization
Time Frame
Baseline T1 before randomization
Title
Adherence to the intervention (pilot study with 15 patients)
Description
Number of patients receiving the full dose of the intervention. adverse events, recruitment, screening and randomization, retention in study/loss to follow-up.
Time Frame
From treatment start until 12 weeks following treatment start.
Title
Acceptability of the intervention (pilot study with 15 patients)
Description
Number of patients feeling overwhelmed or burdened by the intervention. Number of patients not completing the intervention due to feeling overwhelmed ro burdened by the intervention.
Time Frame
From treatment start until 12 weeks following treatment start.
Title
Level of electronic health literacy
Description
The Electronic Health Literacy Questionnaire (e-HLQ) (44) will be used to measure patients level of electronic health literacy prior to, and six months following surgery. In this study, 4 domains will be assessed: 1) using technology to process health information, 2) understanding of health concepts and language, 3) ability to actively engage with digital services, 4) motivated to engage with digital services. The scores range 1-4, with high scores indicating high e-health literacy.
Time Frame
Before treatment start, 6 months after treatment start
Title
Level of health literacy
Description
The International Health Literacy Population survey Questionnaire 2019-2021(HLS19-Q47) will be used to measure patients' level of health literacy prior to, and six months following surgery. The original HLS-19-Q47 consist of 47 items. In this study, 2 domains will be assessed: 1) Health promotion and 2) General health literacy.
Time Frame
Before treatment start, 6 months after treatment start

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
79 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Scheduled for TKA for OA at Lovisenberg, Oslo; Martina Hansen, Bærum, or Coastal Hospital Hagevik, Bergen Age 18 - 79 years ASA grade 1-3 KL grade 3 or 4 BMI<40 Able to read and write in Norwegian Exclusion Criteria: Diagnosis of dementia or sero-positive rheumatic disease Previously undergone uni or patellofemoral prosthesis in the index knee Large axis deviation or instability requiring use of hinged implants Scheduled for unicompartmental arthroplasty or revision surgery
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Maren Falch Lindberg, PhD
Phone
+4794815762
Email
mfli@lds.no
First Name & Middle Initial & Last Name or Official Title & Degree
Anners Lerdal, PhD
Phone
+4795033144
Email
anners.lerdal@medisin.uio.no
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Anners Lerdal, PhD
Organizational Affiliation
Lovisenberg Diaconal Hospital, University of Oslo
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Arild Aamodt, PhD
Organizational Affiliation
Lovisenberg Diakonale Hospital
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Maren F Lindberg, PhD
Organizational Affiliation
Lovisenberg Diakonale Hospital/University of Oslo
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Kari Indrekvam, PhD
Organizational Affiliation
Haukeland University Hospital - Kysthospitalet Hagevik/University of Bergen
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Stig Heir, PhD
Organizational Affiliation
Martina Hansens Hospital
Official's Role
Study Chair
Facility Information:
Facility Name
Haukeland University Hospital - Kysthospitalet Hagevik
City
Bergen
Country
Norway
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Kari Indrekvam, PhD
Phone
+47913 32 899
Email
kari.indrekvam@helse-bergen.no
First Name & Middle Initial & Last Name & Degree
Mona Badawy, PhD
Phone
+4756565927
Email
mona.badawy@helse-bergen.no
First Name & Middle Initial & Last Name & Degree
Turid Rognsvåg, Msc
First Name & Middle Initial & Last Name & Degree
Mona Badawy, PhD
Facility Name
Lovisenberg Diaconal Hospital
City
Oslo
Country
Norway
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Maren F Lindberg, PhD
Phone
+4794815762
Email
m.k.f.lindberg@medisin.uio.no
First Name & Middle Initial & Last Name & Degree
Anners Lerdal, PhD
Phone
22358206
Email
anners.lerdal@medisin.uio.no
First Name & Middle Initial & Last Name & Degree
Anners Lerdal, PhD
First Name & Middle Initial & Last Name & Degree
Arild Aamodt, PhD
Facility Name
Martina Hansens Hospital
City
Oslo
Country
Norway
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Stig Heir, PhD
First Name & Middle Initial & Last Name & Degree
Nina J Kise, PhD

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
34930194
Citation
Lindberg MF, Aamodt A, Badawy M, Bergvad IB, Borchgrevink P, Furnes O, Gay C, Heir S, Holm I, Indrekvam K, Kise N, Lau B, Magnussen J, Nerhus TK, Rognsvag T, Rudsengen DE, Rustoen T, Skou ST, Stubberud J, Smastuen MS, Lerdal A. The effectiveness of exercise therapy and education plus cognitive behavioral therapy, alone or in combination with total knee arthroplasty in patients with knee osteoarthritis - study protocol for the MultiKnee trial. BMC Musculoskelet Disord. 2021 Dec 20;22(1):1054. doi: 10.1186/s12891-021-04924-z.
Results Reference
derived
PubMed Identifier
34696785
Citation
Rognsvag T, Lindberg MF, Lerdal A, Stubberud J, Furnes O, Holm I, Indrekvam K, Lau B, Rudsengen D, Skou ST, Badawy M. Development of an internet-delivered cognitive behavioral therapy program for use in combination with exercise therapy and education by patients at increased risk of chronic pain following total knee arthroplasty. BMC Health Serv Res. 2021 Oct 25;21(1):1151. doi: 10.1186/s12913-021-07177-7.
Results Reference
derived

Learn more about this trial

A Multidisciplinary Intervention in Total Knee Arthroplasty

We'll reach out to this number within 24 hrs